Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Current Deferred Revenue (2018 - 2025)

Inventiva (IVA) posted quarterly Current Deferred Revenue of $3230.7 for Q2 2024, down 50.55% year-over-year from $6533.5 in Q3 2023, and down 49.96% quarter-over-quarter from $6455.6 in Q4 2023.

Analysis

Inventiva (IVA) Current Deferred Revenue (2018 - 2025) Analysis & Trends

Inventiva's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $3230.7 for Q2 2024.

  • In Q2 2024, Current Deferred Revenue fell 50.55% year-over-year to $3230.7; the TTM figure through Jun 2024 stood at $3230.7 (down 50.55% YoY), while the FY2023 annual figure was $6455.6, up 5.46% from the prior year.
  • Current Deferred Revenue for Q2 2024 stood at $3230.7, down from $6455.6 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $6533.5 in Q2 2023, with the low at $3230.7 in Q2 2024.
  • The 3-year median for Current Deferred Revenue is $6288.6 (2022), against an average of $5585.3.
  • The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue rose 5.46% in 2023, then tumbled 50.55% in 2024.
  • Inventiva's Current Deferred Revenue stood at $6121.5 in 2022, then climbed by 5.46% to $6455.6 in 2023, then slumped by 49.96% to $3230.7 in 2024.
  • Business Quant data shows IVA's Current Deferred Revenue at $3230.7 in Q2 2024, $6455.6 in Q4 2023, and $6533.5 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Inventiva 893.85 Mn 893.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.19 Mn
Jun 30, 2024 3,230.66
Dec 31, 2023 6,455.64
Jun 30, 2023 6,533.55
Dec 31, 2022 56.11 Bn
Jun 30, 2022 955,015.74
Dec 31, 2018 625,485.24